← Open Payments lookup

SHIDA BANGASH: Open Payments

NPI 1871159541 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$557 in 31 payments from 14 companies in 2025. Trend: 2023 $175 · 2024 $733 · 2025 $557

Food & beverage: $557
CompanyPaymentsAmount
Novo Nordisk Inc9$168
AstraZeneca Pharmaceuticals LP5$94
ABBVIE INC.3$53
Dexcom, Inc.2$34
GlaxoSmithKline, LLC.2$34
Boehringer Ingelheim Pharmaceuticals, Inc.2$33
GENZYME CORPORATION1$31
Astellas Pharma US Inc1$21
Novartis Pharmaceuticals Corporation1$17
Lilly USA, LLC1$15

Products named: Ozempic, BREZTRI, QULIPTA, Dexcom G6 Transmitter, JARDIANCE, FABRAZYME, AIRSUPRA, Veozah.

Industry payments across MO — which companies pay providers there.